Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort s...
Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study
About this item
Full title
Author / Creator
Publisher
London, England: SAGE Publications
Journal title
Language
English
Formats
Publication information
Publisher
London, England: SAGE Publications
Subjects
More information
Scope and Contents
Contents
Aims:
The HEYMANS study observed patients receiving evolocumab as part of routine clinical hyperlipidemia management. It was designed to capture data on clinical parameters relevant to health authorities and physicians.
Methods:
This was a European multi-country observational cohort serial chart review study; data on the Swiss cohort are r...
Alternative Titles
Full title
Evolocumab use in clinical practice in Switzerland: final data of the observational HEYMANS cohort study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_58b98b728b024679b9fcd7d1a1dd70f7
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_58b98b728b024679b9fcd7d1a1dd70f7
Other Identifiers
ISSN
1753-9447
E-ISSN
1753-9455
DOI
10.1177/17539447231213288
